These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 34668687)

  • 21. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.
    Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D
    J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Myocarditis after COVID-19 vaccination: A case report.
    Schmitt P; Demoulin R; Poyet R; Capilla E; Rohel G; Pons F; Jégo C; Sidibe S; Druelle A; Brocq FX; Dutasta F; Cellarier GR
    Rev Med Interne; 2021 Nov; 42(11):797-800. PubMed ID: 34740463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events.
    Kobayashi H; Fukuda S; Matsukawa R; Asakura Y; Kanno Y; Hatta T; Saito Y; Shimizu Y; Kawarasaki S; Kihara M; Kinoshita N; Umeda H; Noda T; Imamura T; Nishioka Y; Yamaguchi T; Hayashi S; Iguchi T
    Ther Innov Regul Sci; 2023 Mar; 57(2):329-342. PubMed ID: 36310329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021.
    Ilonze OJ; Guglin ME
    Heart Fail Rev; 2022 Nov; 27(6):2033-2043. PubMed ID: 35449353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation.
    Furqan M; Chawla S; Majid M; Mazumdar S; Mahalwar G; Harmon E; Klein A
    Curr Cardiol Rep; 2022 Dec; 24(12):2031-2041. PubMed ID: 36441403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
    Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
    Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.
    Hatziantoniou S; Anastassopoulou C; Lazaros G; Vasileiou K; Tsioufis C; Tsakris A
    Expert Rev Vaccines; 2022 Nov; 21(11):1691-1696. PubMed ID: 35815358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department.
    Liao YF; Tseng WC; Wang JK; Chen YS; Chen CA; Lin MT; Lu CW; Wu MH; Chiu SN
    J Formos Med Assoc; 2023 Aug; 122(8):699-706. PubMed ID: 36564302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination.
    Piché-Renaud PP; Morris SK; Top KA
    Br J Clin Pharmacol; 2023 Mar; 89(3):967-981. PubMed ID: 36480113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis.
    Alami A; Krewski D; Farhat N; Mattison D; Wilson K; Gravel CA; Farrell PJ; Crispo JAG; Haddad N; Perez-Lloret S; Villeneuve PJ
    BMJ Open; 2023 Jun; 13(6):e065687. PubMed ID: 37339840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocarditis and Pericarditis Related to mRNA COVID-19 Vaccination: A Case Report.
    María PLE; Diego RS; Jorge NR
    Curr Drug Saf; 2024; 19(1):154-158. PubMed ID: 36999413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of COVID-19 vaccination and the reported cardiac manifestations.
    Ho JSY; Sia CH; Ngiam JN; Loh PH; Chew NWS; Kong WK; Poh KK
    Singapore Med J; 2023 Sep; 64(9):543-549. PubMed ID: 34808708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 34. Longitudinal Assessment of Left Ventricular Function in Patients with Myopericarditis After mRNA COVID-19 Vaccination.
    Nv B; McCollum S; Faherty E; Steele JM; Karnik R
    Pediatr Cardiol; 2024 Oct; 45(7):1524-1532. PubMed ID: 37294336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination.
    Manno EC; Amodio D; Cotugno N; Rossetti C; Giancotta C; Santilli V; Zangari P; Rotulo GA; Villani A; Giglioni E; Turchetta A; Cafiero G; Franceschini A; Chinali M; Porzio O; Secinaro A; Palma P
    Pediatr Infect Dis J; 2023 Feb; 42(2):166-171. PubMed ID: 36638405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).
    Fix J; Christopher Mast T; Smith K; Baker N
    Vaccine; 2024 Apr; 42(9):2161-2165. PubMed ID: 38494410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.
    Truong DT; Dionne A; Muniz JC; McHugh KE; Portman MA; Lambert LM; Thacker D; Elias MD; Li JS; Toro-Salazar OH; Anderson BR; Atz AM; Bohun CM; Campbell MJ; Chrisant M; D'Addese L; Dummer KB; Forsha D; Frank LH; Frosch OH; Gelehrter SK; Giglia TM; Hebson C; Jain SS; Johnston P; Krishnan A; Lombardi KC; McCrindle BW; Mitchell EC; Miyata K; Mizzi T; Parker RM; Patel JK; Ronai C; Sabati AA; Schauer J; Sexson Tejtel SK; Shea JR; Shekerdemian LS; Srivastava S; Votava-Smith JK; White S; Newburger JW
    Circulation; 2022 Feb; 145(5):345-356. PubMed ID: 34865500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
    Bianchi FP; Rizzi D; Daleno A; Stefanizzi P; Migliore G; Tafuri S
    Int J Infect Dis; 2024 Apr; 141():106960. PubMed ID: 38365084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, Clinical Presentation, and Management of Myocarditis following mRNA-Based Covid-19 Vaccines: A Brief Report.
    Saeed S; Käsk L; Rajani R; Larsen TH
    Cardiology; 2022; 147(4):406-412. PubMed ID: 35104821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines.
    Foltran D; Delmas C; Flumian C; De Paoli P; Salvo F; Gautier S; Drici MD; Karsenty C; Montastruc F
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):99-103. PubMed ID: 34849667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.